CARBOPLATIN

NDC 82511-005 · Teyro Labs Private Limited

Generic nameCARBOPLATIN

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)CARBOPLATIN

Strength450 mg/45mL

Pharmacologic classPlatinum-based Drug [EPC], Platinum-containing Compounds [EXT]

Marketing categoryANDA

Packages

82511-005-45 — 1 VIAL, MULTI-DOSE in 1 CARTON (82511-005-45) / 45 mL in 1 VIAL, MULTI-DOSE

FDA lists these products with the same active ingredient.

60505-6282 — CARBOPLATIN, 61703-150 — Carboplatin, 61703-262 — Carboplatin, 61703-339 — Carboplatin, 61703-360 — Carboplatin, 61703-600 — Carboplatin, 63323-172 — CARBOPLATIN, 68083-190 — Carboplatin, 68083-191 — Carboplatin, 68083-192 — Carboplatin, 68083-193 — Carboplatin, 69339-364 — CARBOPLATIN, 69339-365 — CARBOPLATIN, 69339-366 — CARBOPLATIN, 69339-367 — CARBOPLATIN, 82511-003 — CARBOPLATIN, 82511-004 — CARBOPLATIN, 82511-006 — CARBOPLATIN, 83831-141 — CARBOplatin, 83831-142 — CARBOplatin, +13 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.